Share Name Share Symbol Market Type Share ISIN Share Description
The Biotech Growth Trust LSE:BIOG London Ordinary Share GB0000385517 ORD 25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -8.00p -1.02% 779.50p 776.00p 780.50p 780.00p 775.00p 775.00p 35,694 16:35:05
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Equity Investment Instruments 1.8 1.1 1.3 599.6 435.27

Biotech Growth Trust (BIOG) Latest News (1)

More Biotech Growth Trust News
Biotech Growth Trust Takeover Rumours

Biotech Growth Trust (BIOG) Share Charts

1 Year Biotech Growth Trust Chart

1 Year Biotech Growth Trust Chart

1 Month Biotech Growth Trust Chart

1 Month Biotech Growth Trust Chart

Intraday Biotech Growth Trust Chart

Intraday Biotech Growth Trust Chart

Biotech Growth Trust (BIOG) Discussions and Chat

Biotech Growth Trust Forums and Chat

Date Time Title Posts
22/6/201705:28Biotech Growth Trust PLC (The)285

Add a New Thread

Biotech Growth Trust (BIOG) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2017-08-18 16:15:00801.0015,800126,558.00OK
2017-08-18 15:35:05779.505,12539,949.38UT
2017-08-18 15:29:12776.946655,166.65O
2017-08-18 15:12:28776.504833,750.50O
2017-08-18 14:35:30780.881,0007,808.75O
View all Biotech Growth Trust trades in real-time

Biotech Growth Trust (BIOG) Top Chat Posts

DateSubject
18/8/2017
09:20
Biotech Growth Trust Daily Update: The Biotech Growth Trust is listed in the Equity Investment Instruments sector of the London Stock Exchange with ticker BIOG. The last closing price for Biotech Growth Trust was 787.50p.
The Biotech Growth Trust has a 4 week average price of 770p and a 12 week average price of 705.25p.
The 1 year high share price is 840p while the 1 year low share price is currently 600.50p.
There are currently 55,839,913 shares in issue and the average daily traded volume is 50,922 shares. The market capitalisation of The Biotech Growth Trust is £435,272,121.84.
22/11/2014
20:58
philo124: Just read their Report and Accounts; not sure I should have sold even at these levels- looks like the story and share price has further to go in 2015.
10/4/2014
13:26
urgentclick: Looks good to me: downside recently around 409p (I picked up 1000 at that price point) and upside 550p not long ago. And the NAV comfortably exceeding the share price.
14/1/2013
00:50
yiyack3: In my experience many AIM companies are pretty well worthless, run by a CEO and a crony or two who like the good life, first class on expenses, get rich as quick as poss and don't worry when the company runs out of cash, goes bust and all the shareholders lose their investments. If an AIM company gets to be popular on the ADVFN and other bulletin boards, do what you can to hitch a ride on rising share price, then take profits and get out. Don't ever believe the story behind an AIM market share
29/7/2012
20:24
northernlass: THE QUARTER'S BEST PERFORMER Looking at individual investment portfolios, the Biotech Growth trust was the quarter's best performer in terms of both net asset value (NAV) and share price. Over the three months, its NAV rose 19.1% while share price was up 11.4% on a total return basis. Source: http://www.fundweb.co.uk/investment-trusts/news/trusts-ahead-of-open-ended-peers-despite-q2-underperformance/1053944.article
21/7/2010
18:33
chingman: Latest from Edison - The Biotech Growth Trust Plc (BIOG) has put in a respectable performance during the past 12 months, outperforming its benchmark, the NASDAQ Biotechnology Index (sterling adjusted), by 2.8% in terms of NAV total return and 3.9% in terms of share price total return. The manager believes that concerns over US healthcare reform were overdone and, while this cloud of uncertainty has lifted, concerns regarding the outlook in Europe have delayed the reversion. Looking forward, the manager considers that; biotech will be a net beneficiary of healthcare reform; the regulatory environment will continue to improve; M
26/1/2010
19:28
damanko: Ian - two is a crowd ............... I didn't bother participating in the recent fund raising, as the amount payable (ie the stated NAV) was some way north of the share price. In fact, I meant to write to the board, and ask who on earth would bother (amongst longer term holders) - when this was the case. Whatever, the institutions were keen, and the price has carried on its mild upward trend. Worth tucking away. Mind you, having bought about nine years ago, I'm now only 25% or so down on what I paid. Ho hum....
Biotech Growth Trust share price data is direct from the London Stock Exchange
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:43 V: D:20170819 05:41:59